GLP-1 agonists should be made in collaboration with your healthcare team, considering your individual health needs, weight loss goals, and lifestyle
The paradigm for treating people with obesity has often been to recommend lifestyle changes, and then if they develop diabetes or another metabolic condition, to treat them with metformin, insulin, or GLP-1 drugs, says study senior and corresponding author Andrew Stokes, associate professor of global health
9 In a study of RP patients, Campochiaro et al
doi: 10.2337/diabetes.48.5.1026 88 ThorkildsenCNeveSLarsenBDMeierEPetersenJS
This new review looked at 48 different studies involving people who took medications like Liraglutide, Semaglutide and Tirzepatide for weight loss